MicroRNAs may solve the mystery of chronic hepatitis B virus infection

Ying-Feng Wei1, Guang-Ying Cui, Ping Ye

  • 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medical, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.

Insights

Hepatitis B virus (HBV) infection causes severe liver disease. MicroRNAs (miRNAs) are key in HBV interaction, potentially serving as diagnostic biomarkers and therapeutic targets for better treatment outcomes.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Virology

Background:

  • Hepatitis B virus (HBV) infection is a major global health concern, leading to chronic liver diseases like cirrhosis and hepatocellular carcinoma.
  • The precise pathogenesis of HBV-related diseases remains unclear, and current treatments are suboptimal.
  • MicroRNAs (miRNAs), small noncoding RNAs regulating gene expression, are increasingly recognized for their role in physiological and pathological processes, including host-virus interactions.

Purpose of the Study:

  • To explore the role of microRNAs (miRNAs) in Hepatitis B virus (HBV) infection and associated liver diseases.
  • To investigate miRNAs as potential biomarkers for HBV diagnosis and prognosis.
  • To assess the therapeutic potential of miRNA-based strategies for HBV-related conditions.

Main Methods:

  • Review of existing literature on miRNA expression patterns in HBV infection.
  • Analysis of studies investigating the involvement of differentially expressed miRNAs in HBV pathogenesis, including liver tumorigenesis and metastasis.
  • Examination of research on circulating miRNAs as diagnostic and prognostic markers.
  • Evaluation of preclinical and clinical studies on miRNA-based therapeutic approaches for HBV.

Main Results:

  • HBV infection alters cellular miRNA expression profiles, with distinct miRNA signatures observed at different disease stages.
  • Specific miRNAs are implicated in the progression of HBV-related liver diseases, including liver cancer development and spread.
  • Circulating miRNAs in serum or plasma show promise as non-invasive biomarkers for diagnosing and predicting the prognosis of HBV-related diseases.
  • miRNA-based therapies are emerging as a promising future direction for treating HBV-related conditions.

Conclusions:

  • MicroRNAs play a significant role in the host-HBV interaction and the pathogenesis of HBV-related liver diseases.
  • miRNAs represent valuable biomarkers for the diagnosis and prognosis of HBV infection.
  • miRNA-targeted therapies offer a promising avenue for the future treatment of Hepatitis B virus-related diseases.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...